Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-center Study for the Treatment of Chinese Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma Using a Modified COG Strategy

NCT04726501 is registered in ClinicalTrials.gov with Children's Cancer Group, China as lead sponsor.

NCT NCT04726501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04726501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-center Study for the Treatment of Chinese Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma Using a Modified COG Strategy
Lead sponsor
Children's Cancer Group, China
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 1, 2018
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma